ARTV (STOCKS)
Artiva Biotherapeutics, Inc. Common Stock
$3.868400
-0.021600 (-0.56%)
Prev close: $3.890000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Fred Aslan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $94.74M
- Employees
- 105
- P/E (TTM)
- -1.19
- P/B (TTM)
- 0.73
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $6.96M |
| Operating Expenses | $86.15M |
| Research and Development | $65.86M |
| Other Operating Expenses | $20.28M |
| Operating Income/Loss | -$86.15M |
| Income/Loss From Continuing Operations After Tax | -$79.19M |
| Income/Loss From Continuing Operations Before Tax | -$128.72M |
| Net Income/Loss | -$79.19M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$79.19M |
| Net Income/Loss Available To Common Stockholders, Basic | -$79.19M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.24 |
| Diluted Earnings Per Share | -$1.24 |
| Basic Average Shares | 28,776,933 |
| Diluted Average Shares | 28,776,933 |
| Assets | $148.86M |
| Current Assets | $129.52M |
| Cash | $123.00M |
| Other Current Assets | $6.52M |
| Noncurrent Assets | $19.34M |
| Fixed Assets | $6.98M |
| Other Non-current Assets | $12.36M |
| Liabilities | $19.64M |
| Current Liabilities | $11.12M |
| Accounts Payable | $848.00K |
| Wages | $5.64M |
| Other Current Liabilities | $4.63M |
| Noncurrent Liabilities | $8.52M |
| Equity | $129.22M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $129.22M |
| Liabilities And Equity | $148.86M |
| Net Cash Flow From Operating Activities | -$76.68M |
| Net Cash Flow From Operating Activities, Continuing | -$76.68M |
| Net Cash Flow From Investing Activities | $46.41M |
| Net Cash Flow From Investing Activities, Continuing | $46.41M |
| Net Cash Flow From Financing Activities | $100.00K |
| Net Cash Flow From Financing Activities, Continuing | $100.00K |
| Net Cash Flow | -$30.17M |
| Net Cash Flow, Continuing | -$30.17M |
| Comprehensive Income/Loss | -$79.44M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$79.44M |
| Other Comprehensive Income/Loss | -$79.44M |